Syquant Capital’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Syquant Capital's CELG Position: Q4 2019 in Review
Syquant Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 619,700 shares — an estimated $61.5M sold.
Syquant Capital first reported a position in CELG in Q2 2019 and held it in 2 quarters. The position peaked at $61.5M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Syquant Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Syquant Capital sold 619,700 Celgene Corp shares in Q4 2019, an estimated $61.5M.
- Syquant Capital first reported a position in Celgene Corp in Q2 2019 and held it in 2 quarters.
- Syquant Capital's Celgene Corp position peaked at $61.5M in Q3 2019.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Syquant Capital's 13F filing for Q4 2019, filed 8 Jan 2020.